Nuvectis gains two experimental drugs in licensing deal with China's Haisco
- Posted on June 22, 2026
- By Bing News
- 0 Views
- 1 min read
Nuvectis gains two experimental drugs in licensing deal with China's Haisco
By Sahil Pandey June 22 (Reuters) - Nuvectis Pharma said on Monday it had licensed exclusive rights outside China to two experimental drugs from Haisco Pharmaceutical Group, targeting complement-mediated diseases and cancer to broaden its pipeline. Here are some details of the deal: • Nuvectis has secured exclusive rights outside China to NXP100, an experimental once-daily oral drug for
